Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about REST: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
REST is a gene implicated in neurodegeneration research. Key relationships include: regulates, activates, associated with. Associated with ALS, Aging, Als. Connected to 157 entities in the SciDEX knowledge graph.
| Gene Symbol | REST |
| Full Name | RE1-Silencing Transcription Factor |
| Chromosome | 4q12 |
| Protein Type | Transcription Factor |
| Function | REST (also known as NRSF) is a zinc-finger transcription factor that represses neuronal gene expression in non-neuronal cells and regulates synaptic plasticity in neurons. |
| Pathways | Autophagy, Circadian Rhythm, Epigenetic, Immune Response, Lipid Metabolism |
| UniProt ID | Q9Y2W1 |
| NCBI Gene ID | 5978 |
| Ensembl ID | ENSG00000100647 |
| OMIM | 600571 |
| GeneCards | REST |
| Human Protein Atlas | REST |
| Associated Diseases | Aging, Als, Alzheimer, Alzheimer's disease, Ataxia, Atherosclerosis |
| Interactions | CD2AP, NRF2, P38, CREB1, PPARGC1A, REELIN |
| KG Connections | 330 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
graph TD
REST["REST"] -->|"protects against"| Dementia["Dementia"]
REST["REST"] -->|"regulates"| OGDHL["OGDHL"]
REST["REST"] -.->|"inhibits"| Alzheimer["Alzheimer"]
REST["REST"] -.->|"inhibits"| Ms["Ms"]
REST["REST"] -.->|"inhibits"| Als["Als"]
REST["REST"] -.->|"inhibits"| Aging["Aging"]
CD2AP["CD2AP"] -->|"activates"| REST["REST"]
NRF2["NRF2"] -->|"activates"| REST["REST"]
CLOCK["CLOCK"] -->|"regulates"| REST["REST"]
GENES["GENES"] -->|"regulates"| REST["REST"]
style REST fill:#4a1a6b,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Parkinson | associated_with | disease | 0.85 |
| SYP | co_expressed_with | protein | 0.75 |
| Als | inhibits | disease | 0.75 |
| Alzheimer | associated_with | disease | 0.75 |
| Als | regulates | disease | 0.75 |
| Tumor | inhibits | disease | 0.75 |
| Cancer | therapeutic_target | disease | 0.75 |
| Aging | associated_with | disease | 0.75 |
| Als | associated_with | disease | 0.75 |
| PARKINSON'S DISEASE | associated_with | gene | 0.70 |
| PARKINSON | associated_with | gene | 0.70 |
| oxidative stress response | participates_in | pathway | 0.70 |
| Alzheimer | inhibits | disease | 0.65 |
| Ms | inhibits | disease | 0.65 |
| Aging | inhibits | disease | 0.65 |
| Neurodegeneration | activates | disease | 0.65 |
| Ms | associated_with | disease | 0.65 |
| Als | activates | disease | 0.65 |
| Aging | expressed_in | disease | 0.65 |
| Als | expressed_in | disease | 0.65 |
| Ms | regulates | disease | 0.65 |
| Obesity | regulates | disease | 0.65 |
| Amyotrophic Lateral Sclerosis | regulates | disease | 0.65 |
| Ms | expressed_in | disease | 0.65 |
| ALS | inhibits | disease | 0.65 |
| ALS | activates | disease | 0.65 |
| Cardiovascular | therapeutic_target | disease | 0.65 |
| Neuroinflammation | expressed_in | disease | 0.65 |
| Parkinson | causes | disease | 0.65 |
| Inflammation | expressed_in | disease | 0.65 |
| Chronic Kidney Disease | associated_with | disease | 0.65 |
| Atherosclerosis | associated_with | disease | 0.65 |
| Neurodegeneration | associated_with | disease | 0.65 |
| Prostate Cancer | therapeutic_target | disease | 0.65 |
| Cancer | activates | disease | 0.65 |
| Lung Cancer | activates | disease | 0.65 |
| Inflammation | biomarker_for | disease | 0.65 |
| Parkinson | biomarker_for | disease | 0.65 |
| Amyotrophic Lateral Sclerosis | biomarker_for | disease | 0.65 |
| Als | treats | disease | 0.65 |
| Depression | associated_with | disease | 0.65 |
| Ataxia | associated_with | disease | 0.65 |
| Dystonia | associated_with | disease | 0.65 |
| Dementia | associated_with | disease | 0.65 |
| Infection | regulates | disease | 0.65 |
| Als | contributes_to | disease | 0.65 |
| Autoimmune | activates | disease | 0.65 |
| Inflammation | therapeutic_target | disease | 0.65 |
| Neuroinflammation | activates | disease | 0.65 |
| Alzheimer | activates | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| GENES | regulates | gene | 0.70 |
| PARKINSON'S DISEASE | associated_with | gene | 0.70 |
| PARKINSON | associated_with | gene | 0.70 |
| CD2AP | activates | gene | 0.60 |
| NRF2 | activates | gene | 0.60 |
| CLOCK | regulates | gene | 0.60 |
| EEF2 | inhibits | gene | 0.60 |
| CLOCK | associated_with | gene | 0.60 |
| REELIN | activates | gene | 0.60 |
| EGFR | associated_with | gene | 0.60 |
| PTEN | inhibits | gene | 0.60 |
| TP53 | inhibits | gene | 0.60 |
| EGFR | activates | gene | 0.60 |
| OPTN | causes | gene | 0.60 |
| BDNF | causes | gene | 0.60 |
| RIPK3 | regulates | gene | 0.60 |
| MLKL | regulates | gene | 0.60 |
| RIPK1 | regulates | gene | 0.60 |
| P62 | regulates | gene | 0.60 |
| CD2AP | inhibits | entity | 0.60 |
| CD2AP | regulates | entity | 0.60 |
| MTOR | activates | gene | 0.60 |
| GRIA1 | regulates | gene | 0.60 |
| BDNF | inhibits | gene | 0.60 |
| PSD95 | inhibits | gene | 0.60 |
| HDAC4 | regulates | gene | 0.60 |
| SYN1 | regulates | gene | 0.60 |
| GRM3 | regulates | gene | 0.60 |
| NRF2 | protects_against | gene | 0.60 |
| P38 | inhibits | gene | 0.60 |
| MTDNA | regulates | gene | 0.60 |
| ALZHEIMER'S DISEASE | inhibits | gene | 0.60 |
| NEURON | inhibits | gene | 0.60 |
| MITOCHONDRIAL DYSFUNCTION | activates | gene | 0.60 |
| OXIDATIVE STRESS | activates | gene | 0.60 |
| MITOPHAGY | activates | gene | 0.60 |
| NEURON | activates | gene | 0.60 |
| ALZHEIMER | inhibits | gene | 0.60 |
| MITOCHONDRIA | associated_with | gene | 0.60 |
| MITOCHONDRIA | inhibits | gene | 0.60 |
| NEURODEGENERATION | activates | gene | 0.60 |
| PARKINSON'S DISEASE | causes | gene | 0.60 |
| PARKINSON | causes | gene | 0.60 |
| NEURODEGENERATIVE DISORDERS | causes | gene | 0.60 |
| NEURODEGENERATION | associated_with | gene | 0.60 |
| ALZHEIMER | associated_with | gene | 0.60 |
| PER | associated_with | gene | 0.60 |
| CANCER | therapeutic_target | gene | 0.60 |
| CANCER | activates | gene | 0.60 |
| ASTROCYTES | activates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
Scientific analyses that reference this entity
neurodegeneration | 2026-04-15 | 1 hypotheses Top: 0.497
neurodegeneration | 2026-04-11 | 0 hypotheses
neurodegeneration | 2026-04-11 | 0 hypotheses
neurodegeneration | 2026-04-10 | 0 hypotheses
neuroscience | 2026-04-10 | 0 hypotheses
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Complement C1q/C3-CR3 signaling pathway mediates abnormal microglial phagocytosi [PMID:38642614] | Han QQ, Shen SY, Liang LF, Chen XR, Yu J | Brain Behav Immun | 2024 | 1 |
| Metabolic orchestration of cell death by AMPK-mediated phosphorylation of RIPK1. [PMID:37384704] | Zhang T, Xu D, Trefts E, Lv M, Inuzuka H | Science | 2023 | 1 |
| Anatomical and neurochemical profiles of somatostatin-positive neurons in the mo [PMID:41796787] | Tomioka R, Kobayashi K, Song WJ | Neuroscience | 2026 | 0 |
| Subtype-Specific Roles of Anterior Cingulate Cortex Neurons in Pain-Induced Soci [PMID:41799202] | Wan X, Yan Z, Zhang Z, Liu X, Yang D, Zh | Theranostics | 2026 | 0 |
| A comparative analysis of pig-to-rhesus corneal xenotransplantation with various [PMID:41928466] | Lee SH, Yoon CH, Choi HJ, Lee HJ, Kang H | Korean J Ophthalmol | 2026 | 0 |
| External fixation versus reverse shoulder arthroplasty for proximal humerus frac [PMID:41940987] | Vadalà A, Benelli C, Suraci F, Carta B, | Arch Orthop Trauma Surg | 2026 | 0 |
| Epigenetically regulated pancreatic GABA-somatostatin signaling underlies gestat [PMID:41779871] | Zhu H, Luo S, Liu C, Cheng Y, Ren Z, Mo | Science translational medicine | 2026 | 0 |
| Therapeutic Potential of Somatostatin and Its Analogues in Alzheimer's Disease: [PMID:41854733] | Liu K, Zhang XY, Wang YT, Wang R, Jin RH | Molecular neurobiology | 2026 | 0 |
| Altered Expression of GABA-Related Genes in Schizophrenia: Insights from Meta-An [PMID:41788138] | Singer Y, Yitzhaky A, Hertzberg L | Alpha psychiatry | 2026 | 0 |
| Paracrine inhibition via G protein inwardly rectifying potassium channels regula [PMID:41824458] | Panzer JK, Lang AL, Levi NJ, Garcia PA, | Cell reports | 2026 | 0 |
| Duloxetine Improves Early Clinical Outcomes Including Range of Motion, Functiona [PMID:41934361] | Han SC, Han J, Min YK, Han JW, Jeong HJ | Am J Sports Med | 2026 | 0 |
| Modeling and simulation of conducting airways during continuous high-frequency o [PMID:41941967] | Huang X, Francis I, Gu Y, Saha SC | Respir Physiol Neurobiol | 2026 | 0 |
| Potential antidepressant properties of aminophylline in male mice exposed to chr [PMID:41945313] | Samante FI, Galangue CG, Avelino DC, Bel | Pharmacol Rep | 2026 | 0 |
| Robot-assisted immediate implant placement with the socket shield technique in t [PMID:41963213] | Wu J, Lin B, Yang S, Xu S, Li S | J Prosthet Dent | 2026 | 0 |
| Gray matter structural and molecular signatures in Alzheimer's disease and late- [PMID:41419068] | Yang S, Wang X, Yan Y, Zhang J, Wei Y et | J Affect Disord | 2026 | 0 |
| GADD45G operates as a pathological sensor orchestrating reactive gliosis and neu [PMID:40409253] | Shen T, Tai W, Jiang D, Ma S, Zhong X, Z | Neuron | 2025 | 0 |
| Molecular hallmarks of excitatory and inhibitory neuronal resilience to Alzheime [PMID:41035073] | Castanho I, Naderi Yeganeh P, Boix CA, M | Molecular neurodegeneration | 2025 | 0 |
| The cholesterol 24-hydroxylase CYP46A1 promotes α-synuclein pathology in Parkins [PMID:39964974] | Dai L, Wang J, Meng L, Zhang X, Xiao T, | PLoS biology | 2025 | 0 |
| Molecular hallmarks of excitatory and inhibitory neuronal resilience and resista [PMID:39868232] | Castanho I, Yeganeh PN, Boix CA, Morgan | bioRxiv : the preprint server | 2025 | 0 |
| From stress to Alzheimer's: A circuit-based framework for prefrontal cognitive d [PMID:41115499] | Yi JH | Neuroscience letters | 2025 | 0 |